Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ring finger protein 181 pseudogene (LOC100131785, ENSG00000223886) is classified as a pseudogene, meaning it is a non-functional segment of DNA that resembles a gene but typically does not encode a protein. It is not considered a protein-coding gene nor a therapeutic target[1][5]. Consequently, it does not possess known biological functions, disease associations, or drug interactions. The functional, protein-coding version of this gene is referred to as "Ring finger protein 181" (RNF181), which is an E3 ubiquitin ligase; however, this entry specifically refers to the non-functional pseudogene, not the protein-coding gene[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 181 pseudogene.